Skip to main content
36°
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Illumina, Inc. - Common Stock
(NQ:
ILMN
)
84.05
-0.15 (-0.18%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Illumina, Inc. - Common Stock
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
31
32
Next >
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via
Benzinga
Is Illumina Cheap or Expensive?
December 14, 2022
It depends on which numbers you focus on.
Via
The Motley Fool
What Does Illumina's Debt Look Like?
January 04, 2023
Shares of Illumina Inc. (NASDAQ:ILMN) moved higher by 1.43% in the past three months. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
December 12, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
December 12, 2022
Via
Benzinga
What 7 Analyst Ratings Have To Say About Illumina
December 07, 2022
Via
Benzinga
Looking Into Illumina's Return On Invested Capital
November 21, 2022
Via
Benzinga
Genotek (Yerevan, Armenia), Professor Tamara Sarkisian and Illumina open a world-class genomic laboratory
November 18, 2022
The modern laboratory complex, complete with genomic sequencers and microarray analysis platforms from the U.S. company Illumina, helps solve problems in medical research and agriculture. In addition...
Via
PRUnderground
Topics
Economy
Exposures
Economy
GRAIL CCGA Discovery Results Published in Cancer Cell Reveal Methylation as Promising DNA Hallmark for Multi-Cancer Early Detection
November 17, 2022
From
GRAIL, LLC
Via
Business Wire
Elon Musk' Lost Millions' Over $8 'Blue Check' Fixation, FTX Hacker Holds $339M In Crypto, Amazon To Cut Workforce Starting This Week: Top Stories Tuesday, Nov. 15
November 15, 2022
Reuters
Via
Benzinga
What 12 Analyst Ratings Have To Say About Illumina
November 07, 2022
Within the last quarter, Illumina (NASDAQ:ILMN) has observed the following analyst ratings:
Via
Benzinga
11 Analysts Have This to Say About Illumina
November 04, 2022
Within the last quarter, Illumina (NASDAQ:ILMN) has observed the following analyst ratings:
Via
Benzinga
Illumina Slashes 5% Of Its Workforce
November 15, 2022
Illumina Inc (NASDAQ: ILMN) is cutting 5% of its global workforce to realign its operating expenses to reflect the current macroeconomic environment.
Via
Benzinga
Amazon To $103? Plus Piper Sandler Predicts $300 For Illumina
November 14, 2022
Rosenblatt boosted the price target on Amazon.com, Inc. (NASDAQ: AMZN) from $118 to $103. Rosenblatt analyst Barton Crockett maintained the stock with a Neutral rating. Amazon shares fell 4.3% to close...
Via
Benzinga
$1000 Invested In Illumina 15 Years Ago Would Be Worth This Much Today
November 10, 2022
Illumina (NASDAQ:ILMN) has outperformed the market over the past 15 years by 8.91% on an annualized basis producing an average annual return of 15.72%. Currently, Illumina has a market capitalization...
Via
Benzinga
Stock Market Rally Tumbles On Hawkish Fed Chief Powell; Jobs, Earnings Also In Focus: Weekly Review
November 04, 2022
A mixed jobs report and heavy earnings swung stocks.
Via
Investor's Business Daily
This Growth Stock Rose Last Week. Is It Still a Buy?
October 18, 2022
Illumina is the dominant player in gene sequencing.
Via
The Motley Fool
Musk Reportedly Suspends Twitter Work On Crypto Wallet, Boeing's Jeppesen Hit By Potential Ransomware Attack, Lyft Cuts Workforce: Top Stories Friday, Nov. 04
November 04, 2022
Reuters
Via
Benzinga
Illumina's Q3 Profits Hit By Impairment Of Almost $4B, Cuts Annual Guidance
November 04, 2022
Via
Benzinga
Illumina Plummets On Light Earnings Guidance Despite Quarterly Beat
November 03, 2022
Illumina posted a wide miss for its full-year adjusted earnings outlook, leading shares to tumble after hours.
Via
Investor's Business Daily
$1000 Invested In Illumina 20 Years Ago Would Be Worth This Much Today
November 01, 2022
Illumina (NASDAQ:ILMN) has outperformed the market over the past 20 years by 18.98% on an annualized basis producing an average annual return of 26.53%. Currently, Illumina has a market capitalization...
Via
Benzinga
Ranking 7 Top Tech Stocks to Buy From Biggest to Smallest
October 28, 2022
Although "Big Tech" is currently struggling, but there are still many good top tech stocks to buy at this point.
Via
InvestorPlace
Wall Street Is Still Bullish on This Punished Growth Stock -- Is It a Buy?
October 27, 2022
Bionano's stock price movements have little to do with its successes.
Via
The Motley Fool
Illumina Gains But Lags Market: What You Should Know
October 24, 2022
In the latest trading session, Illumina (ILMN) closed at $220.57, marking a +0.25% move from the previous day. This move lagged the S&P 500's daily gain of 1.19%. Meanwhile, the Dow gained 1.34%, and...
Via
Talk Markets
Companion Diagnostics Industry to Witness Emergence of Players Including Abbott Laboratories, - bioMerieux, Illumina, Agilent Technologies, and Thermo Fisher Scientific –
October 18, 2022
This press release was orginally distributed by SBWire
Via
ReleaseWire
Companion Diagnostics Industry to Witness Emergence of Players Including Abbott Laboratories, - bioMerieux, Illumina, Agilent Technologies, and Thermo Fisher Scientific –
October 18, 2022
London, UK -- (SBWIRE) -- 10/18/2022 -- The latest publication titled Companion Diagnostics – Thematic Research has been added to GlobalData Plc report store. Companion diagnostics (CDx) are molecular...
Via
SBWire
Universal Sequencing Technology Corporation Announces High-Throughput Solution For NGS Library Preparation
October 24, 2022
UST releases high-throughput solution enabling second-generation short-read sequencers to produce long-range results in greater capacity.CARLSBAD, Calif. - Oct. 24, 2022 - PRLog -- Universal Sequencing...
Via
PRLog
Topics
Intellectual Property
Exposures
Intellectual Property
Illumina Inks AI Pact With AstraZeneca To Accelerate Drug Target Discovery
October 11, 2022
Via
Benzinga
Why Bio-Rad Laboratories' Rumored $10 Billion Qiagen Buyout Looks Unlikely
October 11, 2022
One analyst doubts any deal could come to fruition. If it did, it would make sense.
Via
Investor's Business Daily
Here's How Much You Would Have Made Owning Illumina Stock In The Last 20 Years
October 06, 2022
Illumina (NASDAQ:ILMN) has outperformed the market over the past 20 years by 19.07% on an annualized basis producing an average annual return of 26.54%. Currently, Illumina has a market capitalization...
Via
Benzinga
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
31
32
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.